MBCL-52. ENDOCRINE PROFILE AFTER MEDULLOBLASTOMA TREATMENT

BACKGROUND: Treatment of medulloblastoma has evolved substantially with more chemotherapy, risk-adapted dosing of radiotherapy (RT) and new RT techniques. We present the endocrine profile for our patients treated over a 20-year period. METHODS: The charts of patients treated for medulloblastoma betw...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Pavon-Mengual, Miriam, Curry, Helen, Saraff, Vrinda, Mohamed, Zainaba, Benghiat, Helen, Ford, Daniel, Peet, Andrew, Adamski, Jenny, English, Martin
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2020
Onderwerpen:
Medulloblastoma (Clinical)
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715513/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.521
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items